Cell and gene therapies are at a pivot point. These breakthrough therapies show big promise — but the business models to support these new advances are racing to catch up with the science. Can we keep up the pace in the current climate? Find out at Cell & Gene Day 2024, a free virtual event, WATCH ON DEMAND HERE.
Cell & Gene Day 2023 is hosted by Endpoints News and co-sponsored by Precision For Medicine. Carefully curated, this experience gives you access to the latest thinking on cell and gene therapy research and development, manufacturing, and commercialization. You will hear from successful innovators from each facet of the advanced therapy landscape, including leaders from Alliance for Regenerative Medicine (ARM), Astellas, Sarepta, Obsidian Tx, and more.
- Innovations in motion: 2024 outlook for advanced therapies
- [Moderator] Anshul Mangal, President (Project Farma)
- Tim Hunt, CEO (ARM)
- Tony Khoury, EVP (Project Farma)
- Alberto Santagostino, SVP, Head of Cell and Gene Technology (Lonza)
- Curran Simpson, COO (REGENXBIO)
- Richard Wilson, SVP, Primary Focus Lead, Genetic Regulation (Astellas Pharma)
- Fireside chat with Sarepta CEO Doug Ingram
- [Moderator] Lei Lei Wu, Reporter (Endpoints News)
- Douglas S. Ingram, President and Chief Executive Officer (Sarepta Therapeutics)
- The clinical development roadmap for cell and gene therapy
- [Moderator] Andy Kinley, VP, Innovation & Clinical Science (Precision for Medicine)
- Moya Daniels, CQO (Diakonos Oncology, Inc)
- Phil Cyr, SVP (Precision Value and Health)
- Madan Jagasia, CEO (Obsidian Therapeutics)
- Deborah Phippard, CSO (Precision for Medicine)